CLNN Logo

Clene Inc. (CLNN) 

NASDAQ$4.56
Market Cap
$37.97M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
174 of 924
Rank in Industry
108 of 527

CLNN Insider Trading Activity

CLNN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$583,390343
Sells
$22,516457

Related Transactions

MATLIN DAVID Jdirector1$438,4580$0$438,458
Mortenson MarkChief Science Officer1$97,4320$0$97,432
Etherington Robert DeeChief Executive Officer1$47,5000$0$47,500
General Resonance LLC10 percent owner0$04$22,516$-22,516

About Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy â€¦

Insider Activity of Clene Inc.

Over the last 12 months, insiders at Clene Inc. have bought $583,390 and sold $22,516 worth of Clene Inc. stock.

On average, over the past 5 years, insiders at Clene Inc. have bought $6.12M and sold $530,982 worth of stock each year.

Highest buying activity among insiders over the last 12 months: MATLIN DAVID J (director) — $438,458. Mortenson Mark (Chief Science Officer) — $97,432. Etherington Robert Dee (Chief Executive Officer) — $47,500.

The last purchase of 92,307 shares for transaction amount of $438,458 was made by MATLIN DAVID J (director) on 2024‑09‑30.

List of Insider Buy and Sell Transactions, Clene Inc.

2024-09-30PurchaseMATLIN DAVID Jdirector
92,307
1.4829%
$4.75$438,458+3.92%
2024-09-30PurchaseEtherington Robert DeeChief Executive Officer
10,000
0.1606%
$4.75$47,500+3.92%
2024-09-30PurchaseMortenson MarkChief Science Officer
20,512
0.3295%
$4.75$97,432+3.92%
2024-05-01SaleGeneral Resonance LLC10 percent owner
13,000
0.0092%
$0.40$5,148-41.88%
2024-04-30SaleGeneral Resonance LLC10 percent owner
13,000
0.0098%
$0.42$5,416-41.20%
2024-04-24SaleGeneral Resonance LLC10 percent owner
10,000
0.0076%
$0.33$3,278-23.89%
2024-04-09SaleGeneral Resonance LLC10 percent owner
22,500
0.0172%
$0.39$8,675-33.35%
2023-11-10PurchaseMATLIN DAVID Jdirector
250,002
0.1815%
$0.41$102,501-21.11%
2023-06-26PurchaseStevens John Henrydirector
316,455
0.4161%
$0.80$253,164-45.16%
2023-06-26PurchaseEtherington Robert DeeChief Executive Officer
25,000
0.0333%
$0.81$20,250-45.16%
2023-06-16PurchaseUgwumba Chidozie10 percent owner
7.5M
9.259%
$0.80$6M-47.83%
2023-06-16PurchaseMATLIN DAVID Jdirector
1.5M
1.8518%
$0.80$1.2M-47.83%
2023-06-16PurchaseMosca Alisondirector
2.39M
2.9559%
$0.80$1.92M-47.83%
2023-06-16PurchaseGay Jonathondirector
105,625
0.1304%
$0.80$84,500-47.83%
2022-11-02PurchaseUgwumba Chidoziedirector
990,099
1.4746%
$1.01$1,000,000-7.69%
2022-11-02PurchaseMATLIN DAVID Jdirector
2.87M
4.2765%
$1.01$2.9M-7.69%
2022-11-02PurchaseGay Jonathondirector
990,099
1.4746%
$1.01$1,000,000-7.69%
2022-11-02PurchaseMosca Alisondirector
792,079
1.1797%
$1.01$800,000-7.69%
2022-11-02PurchaseStevens John Henrydirector
148,515
0.2212%
$1.01$150,000-7.69%
2022-08-17PurchaseStevens John Henry
47,662
0.0756%
$3.85$183,499-72.25%
Total: 47
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
MATLIN DAVID Jdirector
444491
5.3387%
$2.03M220<0.0001%
Etherington Robert DeeChief Executive Officer
40149
0.4822%
$183,079.4421<0.0001%
Mortenson MarkChief Science Officer
28949
0.3477%
$132,007.4411
Ugwumba Chidozie10 percent owner
13018908
156.3675%
$59.37M20<0.0001%
Mosca Alisondirector
3238375
38.8955%
$14.77M40<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$22,186,116
57
-43.73%
$37.31M
$140,938,207
36
14.75%
$41.76M
Clene Inc.
(CLNN)
$23,895,365
34
-37.28%
$37.97M
$241,165
22
-16.72%
$40.55M
$167,476,357
20
-1.54%
$41.64M

CLNN Institutional Investors: Active Positions

Increased Positions13+50%161,968+15.95%
Decreased Positions9-34.62%688,390-67.78%
New Positions9New114,175New
Sold Out Positions3Sold Out684,257Sold Out
Total Postitions30+15.38%489,213-51.83%

CLNN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$574.001.62%129,620-1,486-1.13%2024-12-31
Scoggin Management Lp$443.001.25%100,000+25,000+33.33%2024-12-31
Geode Capital Management, Llc$288.000.81%65,112+22,539+52.94%2024-12-31
Parsons Capital Management Inc/Ri$162.000.46%36,500+36,500New2024-12-31
Lunt Capital Management, Inc.$132.000.37%29,793+253+0.86%2024-12-31
Citadel Advisors Llc$92.000.26%20,835+20,835New2024-12-31
Renaissance Technologies Llc$80.000.23%18,040+18,040New2024-12-31
Morgan Stanley$75.000.21%16,93100%2024-12-31
Sbi Securities Co., Ltd.$58.000.16%13,025+13,025New2024-12-31
Fullcircle Wealth Llc$58.000.16%13,023+13,023New2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.